Diaphragm Function After Reversal of Rocuronium-induced Neuromuscular

Clinical Trial Summary

This study is to evaluate the recovery of diaphragm function and atelectasis after reversal of neuromuscular blockade with Neostigmine and Sugammadex using lung ultrasound and diaphragm ultrasound for children aged 2 to 7 who are scheduled for the surgical procedure under general anesthesia.

See also
Status	Clinical Trial	Phase
Completed	`NCT03292965` - Monitoring of Postoperative Residual Neuromuscular Blockade in Laparoscopic Surgery	N/A
Not yet recruiting	`NCT05053594` - Different Doses of Neostigmine for Reversal of Moderate Neuromuscular Blockade in Children	Phase 4
Completed	`NCT03831815` - Evaluation of Residual Neuromuscular Blockade and of Late Recurarization in the Post Anesthesia Care Unit in Patients Undergoing Videolaparoscopic Cholecystectomy

See also

Status

Clinical Trial

Phase

Completed

NCT03292965 - Monitoring of Postoperative Residual Neuromuscular Blockade in Laparoscopic Surgery

N/A

Not yet recruiting

NCT05053594 - Different Doses of Neostigmine for Reversal of Moderate Neuromuscular Blockade in Children

Phase 4

Completed

NCT03831815 - Evaluation of Residual Neuromuscular Blockade and of Late Recurarization in the Post Anesthesia Care Unit in Patients Undergoing Videolaparoscopic Cholecystectomy

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05724550
Study type	Interventional
Source	Seoul National University Hospital
Contact	Jung-Bin Park, M.D.
Phone	220723664
Email	jb4001@snu.ac.kr
Status	Recruiting
Phase	N/A
Start date	February 22, 2023
Completion date	April 15, 2025

Diaphragm Function After Reversal of Rocuronium-induced Neuromuscular Blockade With Sugammadex or Neostigmine in Children

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms